Menu
Back to Journals » Vascular Health and Risk Management » Volume 14
Original Research
All-cause mortality, cardiovascular events, and health care costs after 12 months of dual platelet aggregation inhibition after acute myocardial infarction in real-world patients: findings from the Platelet-aggregation Inhibition: Persistence with treatment and cardiovascular Events in Real world (PIPER) study
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 6,385 | Dovepress* | 6,001+ | 1,178 | 7,179 | |
| PubMed Central* | 384 | 139 | 523 | ||
| Totals | 6,385 | 1,317 | 7,702 | ||
| *Since 20 November 2018 | |||||
View citations on PubMed Central and Google Scholar